208 related articles for article (PubMed ID: 12390382)
21. Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution.
Reim D; Loos M; Vogl F; Novotny A; Schuster T; Langer R; Becker K; Höfler H; Siveke J; Bassermann F; Friess H; Schuhmacher C
J Clin Oncol; 2013 Jan; 31(2):263-71. PubMed ID: 23213098
[TBL] [Abstract][Full Text] [Related]
22. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
23. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
Aurello P; D'Angelo F; Rossi S; Bellagamba R; Cicchini C; Nigri G; Ercolani G; De Angelis R; Ramacciato G
Am Surg; 2007 Apr; 73(4):359-66. PubMed ID: 17439029
[TBL] [Abstract][Full Text] [Related]
24. A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa.
Sun Z; Zhu GL; Lu C; Guo PT; Huang BJ; Li K; Xu Y; Wang ZN; Xu HM
Ann Surg; 2009 May; 249(5):768-75. PubMed ID: 19387327
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between metastatic rate and amount of lymph nodes and prognosis of gastric cancer].
Li K; Xu HM; Chen JQ
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2113-6. PubMed ID: 16313820
[TBL] [Abstract][Full Text] [Related]
26. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review.
Aurello P; D'Angelo F; Nigri G; Bellagamba R; Cicchini C; Ruzzetti R; Ramacciato G
Am Surg; 2006 Feb; 72(2):118-23. PubMed ID: 16536239
[TBL] [Abstract][Full Text] [Related]
27. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
28. Problems in the N-classification of the new 1997 UICC TNM stage classification for gastric cancer: an analysis of over 10 years' outcome of Japanese patients.
Nio Y; Yamasawa K; Yamaguchi K; Itakura M; Omori H; Koike M; Kitamura Y; Tsuji M; Endo S; Ogo Y; Yano S; Sumi S
Anticancer Res; 2003; 23(1B):697-705. PubMed ID: 12680170
[TBL] [Abstract][Full Text] [Related]
29. [Impact of new lymph node staging on lymphadenectomy and on the prognosis of patients undergoing surgery for gastric cancer].
Ramacciato G; Aurello P; D'Angelo F; Pezzoli F; Bellagamba R; Nigri G; Cicchini C; Ravaioli M; Ercolani G; Vetrone G; Del Gaudio M; De Angelis R
Chir Ital; 2006; 58(3):285-94. PubMed ID: 16845863
[TBL] [Abstract][Full Text] [Related]
30. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer.
Taylor SH; Merriman KW; Spiess PE; Pisters L
Cancer; 2006 Feb; 106(3):559-65. PubMed ID: 16369982
[TBL] [Abstract][Full Text] [Related]
31. Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer.
Kulig J; Sierzega M; Kolodziejczyk P; Popiela T;
Br J Surg; 2009 Aug; 96(8):910-8. PubMed ID: 19591164
[TBL] [Abstract][Full Text] [Related]
32. Prognostic variables in thoracic esophageal squamous cell carcinoma.
Lin CS; Chang SC; Wei YH; Chou TY; Wu YC; Lin HC; Wang LS; Hsu WH
Ann Thorac Surg; 2009 Apr; 87(4):1056-65. PubMed ID: 19324127
[TBL] [Abstract][Full Text] [Related]
33. Developing an appropriate staging system for esophageal carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
[TBL] [Abstract][Full Text] [Related]
34. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
Coburn NG; Swallow CJ; Kiss A; Law C
Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
[TBL] [Abstract][Full Text] [Related]
35. Proposed modification of nodal status in AJCC esophageal cancer staging system.
Hofstetter W; Correa AM; Bekele N; Ajani JA; Phan A; Komaki RR; Liao Z; Maru D; Wu TT; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Walsh GL; Francis A; Blackmon S; Swisher SG
Ann Thorac Surg; 2007 Aug; 84(2):365-73; discussion 374-5. PubMed ID: 17643602
[TBL] [Abstract][Full Text] [Related]
36. Metastatic lymph node size and colorectal cancer prognosis.
Dhar DK; Yoshimura H; Kinukawa N; Maruyama R; Tachibana M; Kohno H; Kubota H; Nagasue N
J Am Coll Surg; 2005 Jan; 200(1):20-8. PubMed ID: 15631916
[TBL] [Abstract][Full Text] [Related]
37. New TNM staging criteria for head and neck tumors.
O'Sullivan B; Shah J
Semin Surg Oncol; 2003; 21(1):30-42. PubMed ID: 12923914
[TBL] [Abstract][Full Text] [Related]
38. The superiority of the new International Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma.
Hermanek P
Cancer; 2000 Apr; 88(8):1763-5. PubMed ID: 10760749
[No Abstract] [Full Text] [Related]
39. Clinical impact of metastatic lymph node ratio in advanced gastric cancer.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
Anticancer Res; 2005; 25(2B):1369-75. PubMed ID: 15865093
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of positive lymph node ratio in gastric carcinoma.
Celen O; Yildirim E; Berberoglu U
J Surg Oncol; 2007 Aug; 96(2):95-101. PubMed ID: 17443727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
